Demo
BMRA Nasdaq· Biomerica Inc
FundamentalsNews digest Peer analysis
Login
BMRA Nasdaq· Biomerica Inc
Earnings report Q4 2023

Biomérica, Inc. Reports Solid Revenue Growth in Latest Quarter

Segments of revenue

Biomérica, Inc. reported net sales of $1.57 million for the three months ended November 30, 2023, representing a 5.7% increase compared to the same period last year. For the six months ended November 30, 2023, net sales amounted to $3.28 million, reflecting a 5.2% growth compared to the prior year.

Strengths

Biomérica, Inc. demonstrated solid revenue growth in the latest quarter, driven by increased net sales. The company's ability to generate higher sales can be attributed to several factors, including successful product launches, expanded market presence, and effective marketing strategies. Management highlighted the positive impact of new product offerings and increased demand for the company's existing products in driving revenue growth.

Challenges

Despite the overall revenue growth, Biomérica, Inc. faced challenges in managing its cost of sales. The cost of sales for the three months ended November 30, 2023, increased by 9.6% compared to the same period last year, while for the six months ended November 30, 2023, it decreased by 9.9%. This indicates a potential need for the company to optimize its cost structure and improve operational efficiency to enhance profitability.

Noteworthy

Biomérica, Inc. experienced a loss from operations of $1.61 million for the three months ended November 30, 2023, which was slightly lower than the loss of $1.67 million reported in the same period last year. However, the company reported a significant improvement in other income, with interest and dividend income amounting to $109,000 for the latest quarter compared to $41,000 in the prior year. This increase in other income contributed positively to the company's overall financial performance.

Summary

Biomérica, Inc. delivered solid revenue growth in the latest quarter, driven by increased net sales. The company's successful product launches, expanded market presence, and effective marketing strategies contributed to this growth. However, challenges in managing the cost of sales and a loss from operations indicate the need for the company to focus on optimizing its cost structure and improving operational efficiency. The significant improvement in other income highlights a positive aspect of the company's financial performance. Overall, Biomérica, Inc. demonstrated resilience and potential for future growth in the latest quarter.

Source documents

Form 10-Q  filed on Jan 16, 2024
61 pages scanned

Reference data

Company financials Q4 revenue 1.6M
Analyst estimates Q4 EPS missed by NaN%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.